Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors
- DOI
- 10.1016/j.omton.2026.201319
- Published
- 2026-09
- Container
- Molecular Therapy Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201319,
title = {Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors},
author = {Junquan Liu and Ningyan Zhang and Zhiqiang An and Andras Heczey},
year = {2026},
journal = {Molecular Therapy Oncology},
doi = {10.1016/j.omton.2026.201319},
url = {https://doi.org/10.1016/j.omton.2026.201319}
}RIS
TY - JOUR TI - Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors AU - Junquan Liu AU - Ningyan Zhang AU - Zhiqiang An AU - Andras Heczey PY - 2026 JO - Molecular Therapy Oncology DO - 10.1016/j.omton.2026.201319 UR - https://doi.org/10.1016/j.omton.2026.201319 ER -
APA
Liu, J., Zhang, N., An, Z., & Heczey, A. (2026). Interleukin-15-armored ALPPL2 CAR T cells demonstrate robust preclinical efficacy for solid tumors. Molecular Therapy Oncology. https://doi.org/10.1016/j.omton.2026.201319
Source records
- crossref · retrieved 2026-09-25T10:51:16.132Z